{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T05:53:17Z","timestamp":1777873997422,"version":"3.51.4"},"reference-count":105,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T00:00:00Z","timestamp":1765843200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82372960"],"award-info":[{"award-number":["82372960"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["XJZT24LY09"],"award-info":[{"award-number":["XJZT24LY09"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.biopha.2025.118916","type":"journal-article","created":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T11:07:51Z","timestamp":1766056071000},"page":"118916","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Dual faces of USP10 in breast cancer: Oncogenic driver, tumor suppressor, and emerging therapeutic target"],"prefix":"10.1016","volume":"194","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-0389-1888","authenticated-orcid":false,"given":"Cong","family":"Fan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiajia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianing","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mengxuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiajun","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haoyi","family":"Zi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuai","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ting","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2025.118916_bib1","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CaCancer J. Clin."},{"key":"10.1016\/j.biopha.2025.118916_bib2","doi-asserted-by":"crossref","first-page":"477","DOI":"10.3322\/caac.21863","article-title":"Breast cancer statistics 2024","volume":"74","author":"Giaquinto","year":"2024","journal-title":"CaCancer J. Clin."},{"key":"10.1016\/j.biopha.2025.118916_bib3","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1001\/jama.2018.19323","article-title":"Breast cancer treatment: a review","volume":"321","author":"Waks","year":"2019","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.biopha.2025.118916_bib4","article-title":"Breast cancer: pathogenesis and treatments","volume":"10","author":"Xiong","year":"2025","journal-title":"Signal. Transduct. Tar."},{"key":"10.1016\/j.biopha.2025.118916_bib5","doi-asserted-by":"crossref","first-page":"3308","DOI":"10.1158\/1078-0432.CCR-21-3044","article-title":"Perioperative ctDNA-based molecular residual disease detection for non-small cell lung cancer: a prospective multicenter cohort study (LUNGCA-1)","volume":"28","author":"Xia","year":"2022","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.biopha.2025.118916_bib6","article-title":"Genomic alterations and evolution of cell clusters in metastatic invasive micropapillary carcinoma of the breast","volume":"13","author":"Shi","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2025.118916_bib7","doi-asserted-by":"crossref","DOI":"10.1038\/s41556-024-01446-3","article-title":"Loss of or drives brain metastasis via KDM6A-dependent upregulation of MMP3","volume":"26","author":"Seehawer","year":"2024","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.biopha.2025.118916_bib8","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.trecan.2023.06.002","article-title":"Collagen architecture and signaling orchestrate cancer development","volume":"9","author":"Su","year":"2023","journal-title":"Trends Cancer"},{"key":"10.1016\/j.biopha.2025.118916_bib9","first-page":"128","article-title":"Multiomics in primary and metastatic breast tumors from the AURORA US network finds microenvironment and epigenetic drivers of metastasis","volume":"4","author":"Garcia-Recio","year":"2023","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.biopha.2025.118916_bib10","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/s41568-022-00512-y","article-title":"G.C.P. Consorti, Learning to distinguish progressive and non-progressive ductal carcinoma in situ","volume":"22","author":"Casasent","year":"2022","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.biopha.2025.118916_bib11","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.7150\/ijbs.70955","article-title":"Eukaryotic ribosome quality control system: a potential therapeutic target for human diseases","volume":"18","author":"Zhao","year":"2022","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.biopha.2025.118916_bib12","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202102991","article-title":"Dendrimer-like supramolecular assembly of proteins with a tunable size and valency through stepwise iterative growth","volume":"8","author":"Bae","year":"2021","journal-title":"Adv. Sci."},{"key":"10.1016\/j.biopha.2025.118916_bib13","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.3724\/abbs.2022160","article-title":"USP14 regulates cell cycle progression through deubiquitinating CDK1 in breast cancer","volume":"54","author":"Liu","year":"2022","journal-title":"Acta Biochem. Biophys. Sin."},{"key":"10.1016\/j.biopha.2025.118916_bib14","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1002\/mc.23591","article-title":"USP9X deubiquitinates and stabilizes CDC123 to promote breast carcinogenesis through regulating cell cycle","volume":"62","author":"Song","year":"2023","journal-title":"Mol. Carcinog."},{"key":"10.1016\/j.biopha.2025.118916_bib15","doi-asserted-by":"crossref","DOI":"10.1186\/s12943-024-02046-3","article-title":"Ubiquitination and deubiquitination in cancer: from mechanisms to novel therapeutic approaches","volume":"23","author":"Liu","year":"2024","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.biopha.2025.118916_bib16","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1007\/s12272-020-01281-8","article-title":"Ubiquitin-proteasome system (UPS) as a target for anticancer treatment","volume":"43","author":"Park","year":"2020","journal-title":"Arch. Pharm. Res"},{"key":"10.1016\/j.biopha.2025.118916_bib17","doi-asserted-by":"crossref","DOI":"10.1186\/s12943-020-01262-x","article-title":"The role of ubiquitination and deubiquitination in cancer metabolism","volume":"19","author":"Sun","year":"2020","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.biopha.2025.118916_bib18","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nrd.2017.152","article-title":"Deubiquitylating enzymes and drug discovery: emerging opportunities","volume":"17","author":"Harrigan","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.biopha.2025.118916_bib19","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202303807","article-title":"Deubiquitylating enzymes in cancer and immunity","volume":"10","author":"Ren","year":"2023","journal-title":"Adv. Sci."},{"key":"10.1016\/j.biopha.2025.118916_bib20","doi-asserted-by":"crossref","DOI":"10.1186\/s13046-023-02805-y","article-title":"Targeting ubiquitin specific proteases (USPs) in cancer immunotherapy: from basic research to preclinical application","volume":"42","author":"Gao","year":"2023","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.biopha.2025.118916_bib21","doi-asserted-by":"crossref","DOI":"10.1186\/s12929-019-0522-0","article-title":"The role of ubiquitin-specific peptidases in cancer progression","volume":"26","author":"Young","year":"2019","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.biopha.2025.118916_bib22","doi-asserted-by":"crossref","first-page":"51296","DOI":"10.18632\/oncotarget.17261","article-title":"Identification of deubiquitinase targets of isothiocyanates using SILAC-assisted quantitative mass spectrometry","volume":"8","author":"Lawson","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.biopha.2025.118916_bib23","doi-asserted-by":"crossref","DOI":"10.1038\/emm.2017.128","article-title":"Modulating cellular balance of Rps3 mono-ubiquitination by both Hel2 E3 ligase and Ubp3 deubiquitinase regulates protein quality control","volume":"49","author":"Jung","year":"2017","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.biopha.2025.118916_bib24","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1038\/s41419-020-03246-7","article-title":"When the chains do not break: the role of USP10 in physiology and pathology","volume":"11","author":"Bhattacharya","year":"2020","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.biopha.2025.118916_bib25","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s40291-020-00509-z","article-title":"The ubiquitin proteasome system and skin fibrosis","volume":"25","author":"Shen","year":"2021","journal-title":"Mol. Diagn. Ther."},{"key":"10.1016\/j.biopha.2025.118916_bib26","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12092470","article-title":"Revisiting the concept of stress in the prognosis of solid tumors: a role for stress granules proteins?","volume":"12","author":"Aulas","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.biopha.2025.118916_bib27","doi-asserted-by":"crossref","DOI":"10.3390\/genes13050831","article-title":"USP10 as a potential therapeutic target in human cancers","volume":"13","author":"Tao","year":"2022","journal-title":"Genes"},{"key":"10.1016\/j.biopha.2025.118916_bib28","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1038\/s41568-023-00633-y","article-title":"Deubiquitinases in cancer","volume":"23","author":"Dewson","year":"2023","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.biopha.2025.118916_bib29","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/nrm2731","article-title":"Breaking the chains: structure and function of the deubiquitinases","volume":"10","author":"Komander","year":"2009","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.biopha.2025.118916_bib30","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/s41419-022-04566-6","article-title":"Ubiquitin-specific proteases in inflammatory bowel disease-related signalling pathway regulation","volume":"13","author":"Chen","year":"2022","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.biopha.2025.118916_bib31","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.molcel.2016.01.010","article-title":"Deubiquitination and activation of AMPK by USP10","volume":"61","author":"Deng","year":"2016","journal-title":"Mol. Cell"},{"key":"10.1016\/j.biopha.2025.118916_bib32","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1146\/annurev.biochem.78.082307.091526","article-title":"Regulation and cellular roles of ubiquitin-specific deubiquitinating enzymes","volume":"78","author":"Reyes-Turcu","year":"2009","journal-title":"Annu Rev. Biochem."},{"key":"10.1016\/j.biopha.2025.118916_bib33","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1006\/scdb.2000.0164","article-title":"Ubiquitination and deubiquitination: targeting of proteins for degradation by the proteasome","volume":"11","author":"Wilkinson","year":"2000","journal-title":"Semin. Cell Dev. Biol."},{"key":"10.1016\/j.biopha.2025.118916_bib34","doi-asserted-by":"crossref","DOI":"10.3390\/genes13050831","article-title":"USP10 as a potential therapeutic target in human cancers","volume":"13","author":"Tao","year":"2022","journal-title":"Genes"},{"key":"10.1016\/j.biopha.2025.118916_bib35","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.990195","article-title":"Ubiquitin-specific peptidase 10, a deubiquitinating enzyme: assessing its role in tumor prognosis and immune response","volume":"12","author":"Ye","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.biopha.2025.118916_bib36","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1186\/s13046-024-03176-8","article-title":"Recruitment of USP10 by GCS1 to deubiquitinate GRP78 promotes the progression of colorectal cancer via alleviating endoplasmic reticulum stress","volume":"43","author":"Chen","year":"2024","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.biopha.2025.118916_bib37","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1002\/1873-3468.13323","article-title":"USP10 regulates Musashi-2 stability via deubiquitination and promotes tumour proliferation in colon cancer","volume":"593","author":"Ouyang","year":"2019","journal-title":"FEBS Lett."},{"key":"10.1016\/j.biopha.2025.118916_bib38","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/s13046-021-01920-y","article-title":"NLRP7 deubiquitination by USP10 promotes tumor progression and tumor-associated macrophage polarization in colorectal cancer","volume":"40","author":"Li","year":"2021","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.biopha.2025.118916_bib39","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s13046-025-03357-z","article-title":"USP10\/XAB2\/ANXA2 axis promotes DNA damage repair to enhance chemoresistance to oxaliplatin in colorectal cancer","volume":"44","author":"Liu","year":"2025","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.biopha.2025.118916_bib40","doi-asserted-by":"crossref","first-page":"3645","DOI":"10.1038\/s41388-024-03141-x","article-title":"USP10 drives cancer stemness and enables super-competitor signalling in colorectal cancer","volume":"43","author":"Reissland","year":"2024","journal-title":"Oncogene"},{"key":"10.1016\/j.biopha.2025.118916_bib41","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1016\/j.chembiol.2023.07.016","article-title":"USP10 strikes down beta-catenin by dual-wielding deubiquitinase activity and phase separation potential","volume":"30","author":"Wang","year":"2023","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.biopha.2025.118916_bib42","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s13046-023-02654-9","article-title":"LINC00240 in the 6p22.1 risk locus promotes gastric cancer progression through USP10-mediated DDX21 stabilization","volume":"42","author":"Zhang","year":"2023","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.biopha.2025.118916_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.216712","article-title":"Modulation of YBX1-mediated PANoptosis inhibition by PPM1B and USP10 confers chemoresistance to oxaliplatin in gastric cancer","volume":"587","author":"Lin","year":"2024","journal-title":"Cancer Lett."},{"key":"10.1016\/j.biopha.2025.118916_bib44","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1186\/s12885-024-12549-3","article-title":"System-wide identification of novel de-ubiquitination targets for USP10 in gastric cancer metastasis through multi-omics screening","volume":"24","author":"Zeng","year":"2024","journal-title":"Bmc Cancer"},{"key":"10.1016\/j.biopha.2025.118916_bib45","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1038\/s41418-019-0458-7","article-title":"The deubiquitinase USP10 regulates KLF4 stability and suppresses lung tumorigenesis","volume":"27","author":"Wang","year":"2020","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.biopha.2025.118916_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2021.101088","article-title":"The deubiquitinase USP10 restores PTEN activity and inhibits non-small cell lung cancer cell proliferation","volume":"297","author":"He","year":"2021","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2025.118916_bib47","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s13046-022-02266-9","article-title":"HDAC7 promotes NSCLC proliferation and metastasis via stabilization by deubiquitinase USP10 and activation of beta-catenin-FGF18 pathway","volume":"41","author":"Guo","year":"2022","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.biopha.2025.118916_bib48","doi-asserted-by":"crossref","first-page":"23685","DOI":"10.1038\/s41598-024-74490-6","article-title":"USP10 promotes cell proliferation, migration, and invasion in NSCLC through deubiquitination and stabilization of EIF4G1","volume":"14","author":"Li","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2025.118916_bib49","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/s41419-020-2519-8","article-title":"The USP10-HDAC6 axis confers cisplatin resistance in non-small cell lung cancer lacking wild-type p53","volume":"11","author":"Hu","year":"2020","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.biopha.2025.118916_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116468","article-title":"Discovery of potent small molecule ubiquitin-specific protease 10 inhibitors with anti-hepatocellular carcinoma activity through regulating YAP expression","volume":"272","author":"Lu","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.biopha.2025.118916_bib51","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1038\/s12276-024-01223-0","article-title":"Stress-induced epinephrine promotes hepatocellular carcinoma progression via the USP10-PLAGL2 signaling loop","volume":"56","author":"Wang","year":"2024","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.biopha.2025.118916_bib52","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1002\/1878-0261.12596","article-title":"Deubiquitinating enzyme USP10 promotes hepatocellular carcinoma metastasis through deubiquitinating and stabilizing Smad4 protein","volume":"14","author":"Yuan","year":"2020","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.biopha.2025.118916_bib53","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.canlet.2018.07.032","article-title":"USP10 suppresses tumor progression by inhibiting mTOR activation in hepatocellular carcinoma","volume":"436","author":"Lu","year":"2018","journal-title":"Cancer Lett."},{"key":"10.1016\/j.biopha.2025.118916_bib54","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1186\/s12964-024-01805-5","article-title":"NDR1 mediates PD-L1 deubiquitination to promote prostate cancer immune escape via USP10","volume":"22","author":"Fu","year":"2024","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.biopha.2025.118916_bib55","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1186\/s13046-019-1165-4","article-title":"Inhibition of EGFR signaling with Spautin-1 represents a novel therapeutics for prostate cancer","volume":"38","author":"Liao","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.biopha.2025.118916_bib56","doi-asserted-by":"crossref","first-page":"3529","DOI":"10.1093\/nar\/gkq1352","article-title":"USP10 deubiquitylates the histone variant H2A.Z and both are required for androgen receptor-mediated gene activation","volume":"39","author":"Draker","year":"2011","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.biopha.2025.118916_bib57","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s13046-025-03272-3","article-title":"AGD1\/USP10\/METTL13 complexes enhance cancer stem cells proliferation and diminish the therapeutic effect of docetaxel via CD44 m6A modification in castration resistant prostate cancer","volume":"44","author":"Wang","year":"2025","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.biopha.2025.118916_bib58","doi-asserted-by":"crossref","first-page":"553","DOI":"10.21873\/cgp.20157","article-title":"Loss of both USP10 and p14ARF protein expression is an independent prognostic biomarker for poor prognosis in patients with epithelial ovarian cancer","volume":"16","author":"Han","year":"2019","journal-title":"Cancer Genom. Proteom."},{"key":"10.1016\/j.biopha.2025.118916_bib59","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.cell.2009.12.032","article-title":"USP10 regulates p53 localization and stability by deubiquitinating p53","volume":"140","author":"Yuan","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.biopha.2025.118916_bib60","article-title":"The Prognostic value and immune infiltration of USP10 in pan-cancer: a potential therapeutic target","volume":"12","author":"Gao","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.biopha.2025.118916_bib61","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S0092-8674(02)00902-9","article-title":"SUMO-1 modification of Mdm2 prevents its self-ubiquitination and increases Mdm2 ability to ubiquitinate p53","volume":"110","author":"Fuchs","year":"2002","journal-title":"Cell"},{"key":"10.1016\/j.biopha.2025.118916_bib62","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s12943-022-01567-z","article-title":"Hypoxia-induced circWSB1 promotes breast cancer progression through destabilizing p53 by interacting with USP10","volume":"21","author":"Yang","year":"2022","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.biopha.2025.118916_bib63","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.2217\/fon.13.92","article-title":"Role of hypoxia-inducible factors in breast cancer metastasis","volume":"9","author":"Gilkes","year":"2013","journal-title":"Future Oncol."},{"key":"10.1016\/j.biopha.2025.118916_bib64","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1093\/ajcp\/aqac174","article-title":"Expanding the immunophenotypic spectrum of neoplastic and reactive plasmacytoid dendritic cells","volume":"159","author":"Wu","year":"2023","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.biopha.2025.118916_bib65","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2023.115864","article-title":"USP10 promotes the progression of triple-negative breast cancer by enhancing the stability of TCF4 protein","volume":"218","author":"Yang","year":"2023","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.biopha.2025.118916_bib66","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1002\/acn3.51743","article-title":"Exosomal circ-AHCY promotes glioblastoma cell growth via Wnt\/beta-catenin signaling pathway","volume":"10","author":"Li","year":"2023","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.biopha.2025.118916_bib67","article-title":"ARL3 enhances eralpha stability via USP10 deubiquitination to promote endocrine resistance and drive mitochondrial metabolic reprogramming in hr+ breast cancer","author":"Li","year":"2025","journal-title":"Adv. Sci."},{"key":"10.1016\/j.biopha.2025.118916_bib68","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1038\/s41388-025-03428-7","article-title":"The deubiquitination-PARylation positive feedback loop of the USP10-PARP1 axis promotes DNA damage repair and affects therapeutic efficacy of PARP1 inhibitor","volume":"44","author":"Liu","year":"2025","journal-title":"Oncogene"},{"key":"10.1016\/j.biopha.2025.118916_bib69","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1038\/nrm.2017.53","article-title":"The multifaceted roles of PARP1 in DNA repair and chromatin remodelling","volume":"18","author":"Chaudhuri","year":"2017","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.biopha.2025.118916_bib70","doi-asserted-by":"crossref","first-page":"3811","DOI":"10.1093\/nar\/gkz120","article-title":"Poly(ADP-ribosyl)ation by PARP1: reaction mechanism and regulatory proteins","volume":"47","author":"Alemasova","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.biopha.2025.118916_bib71","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.ymthe.2020.09.034","article-title":"Olaparib suppresses MDSC recruitment via SDF1alpha\/CXCR4 axis to improve the anti-tumor efficacy of CAR-T cells on breast cancer in mice","volume":"29","author":"Sun","year":"2021","journal-title":"Mol. Ther."},{"key":"10.1016\/j.biopha.2025.118916_bib72","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1038\/nrm3228","article-title":"All tangled up: how cells direct, manage and exploit topoisomerase function","volume":"12","author":"Vos","year":"2011","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.biopha.2025.118916_bib73","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/nrc3892","article-title":"Topoisomerase-mediated chromosomal break repair: an emerging player in many games","volume":"15","author":"Ashour","year":"2015","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.biopha.2025.118916_bib74","doi-asserted-by":"crossref","first-page":"12638","DOI":"10.1038\/ncomms12638","article-title":"RNF168 and USP10 regulate topoisomerase IIalpha function via opposing effects on its ubiquitylation","volume":"7","author":"Guturi","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2025.118916_bib75","first-page":"7","article-title":"Cancer statistics, 2022","volume":"72","author":"Siegel","year":"2022","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.biopha.2025.118916_bib76","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.cell.2011.09.024","article-title":"Tumor metastasis: molecular insights and evolving paradigms","volume":"147","author":"Valastyan","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.biopha.2025.118916_bib77","doi-asserted-by":"crossref","first-page":"3236","DOI":"10.1038\/s41388-023-02823-2","article-title":"Downregulated circPOKE promotes breast cancer metastasis through activation of the USP10-Snail axis","volume":"42","author":"Luo","year":"2023","journal-title":"Oncogene"},{"key":"10.1016\/j.biopha.2025.118916_bib78","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1038\/s41418-022-00940-1","article-title":"IKBKE phosphorylates and stabilizes Snail to promote breast cancer invasion and metastasis","volume":"29","author":"Xie","year":"2022","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.biopha.2025.118916_bib79","doi-asserted-by":"crossref","first-page":"963","DOI":"10.2174\/15680096113136660102","article-title":"The role of snail in EMT and tumorigenesis","volume":"13","author":"Wang","year":"2013","journal-title":"Curr. Cancer Drug Targets"},{"key":"10.1016\/j.biopha.2025.118916_bib80","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2023.107606","article-title":"DAB2IP suppresses invadopodia formation through destabilizing ALK by interacting with USP10 in breast cancer","volume":"26","author":"Huang","year":"2023","journal-title":"iScience"},{"key":"10.1016\/j.biopha.2025.118916_bib81","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/s41580-022-00530-6","article-title":"Mechanisms and roles of podosomes and invadopodia","volume":"24","author":"Linder","year":"2023","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.biopha.2025.118916_bib82","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.semcancer.2021.03.008","article-title":"Novel molecular regulators of breast cancer stem cell plasticity and heterogeneity","volume":"82","author":"Zhang","year":"2022","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.biopha.2025.118916_bib83","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s13045-019-0711-z","article-title":"Downregulation of RNF128 activates Wnt\/beta-catenin signaling to induce cellular EMT and stemness via CD44 and CTTN ubiquitination in melanoma","volume":"12","author":"Wei","year":"2019","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.biopha.2025.118916_bib84","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1002\/cam4.1968","article-title":"CD44 standard isoform is involved in maintenance of cancer stem cells of a hepatocellular carcinoma cell line","volume":"8","author":"Asai","year":"2019","journal-title":"Cancer Med."},{"key":"10.1016\/j.biopha.2025.118916_bib85","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/s41420-024-01875-x","article-title":"POLE2 promotes osteosarcoma progression by enhancing the stability of CD44","volume":"10","author":"Wang","year":"2024","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.biopha.2025.118916_bib86","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1042\/BCJ20240611","article-title":"USP10 deubiquitinates and stabilizes CD44 leading to enhanced breast cancer cell proliferation, stemness and metastasis","volume":"481","author":"Sethi","year":"2024","journal-title":"Biochem. J."},{"key":"10.1016\/j.biopha.2025.118916_bib87","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1158\/2159-8290.CD-18-0065","article-title":"Homophilic CD44 interactions mediate tumor cell aggregation and polyclonal metastasis in patient-derived breast cancer models","volume":"9","author":"Liu","year":"2019","journal-title":"Cancer Discov."},{"key":"10.1016\/j.biopha.2025.118916_bib88","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/nrm1004","article-title":"CD44: from adhesion molecules to signalling regulators","volume":"4","author":"Ponta","year":"2003","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.biopha.2025.118916_bib89","doi-asserted-by":"crossref","first-page":"4507","DOI":"10.1038\/s41388-020-1303-7","article-title":"YTHDF2 promotes the liver cancer stem cell phenotype and cancer metastasis by regulating OCT4 expression via m6A RNA methylation","volume":"39","author":"Zhang","year":"2020","journal-title":"Oncogene"},{"key":"10.1016\/j.biopha.2025.118916_bib90","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1038\/s41467-021-21514-8","article-title":"RNA m6A methylation orchestrates cancer growth and metastasis via macrophage reprogramming","volume":"12","author":"Yin","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2025.118916_bib91","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/nature11112","article-title":"Topology of the human and mouse m6A RNA methylomes revealed by m6A-seq","volume":"485","author":"Dominissini","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2025.118916_bib92","doi-asserted-by":"crossref","first-page":"449","DOI":"10.7150\/ijbs.76798","article-title":"Stabilization of IGF2BP1 by USP10 promotes breast cancer metastasis via CPT1A in an m6A-dependent manner","volume":"19","author":"Shi","year":"2023","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.biopha.2025.118916_bib93","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/s41417-021-00348-y","article-title":"Fatty acid beta-oxidation promotes breast cancer stemness and metastasis via the miRNA-328-3p-CPT1A pathway","volume":"29","author":"Zeng","year":"2022","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.biopha.2025.118916_bib94","doi-asserted-by":"crossref","first-page":"3365","DOI":"10.1200\/JCO.22.01002","article-title":"Sacituzumab govitecan in hormone receptor-positive\/human epidermal growth factor receptor 2-negative metastatic breast cancer","volume":"40","author":"Rugo","year":"2022","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.biopha.2025.118916_bib95","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2022.102395","article-title":"Combining antibody-drug conjugates with immunotherapy in solid tumors: current landscape and future perspectives","volume":"106","author":"Nicolo","year":"2022","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.biopha.2025.118916_bib96","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202400757","article-title":"Tuning immune-cold tumor by suppressing USP10\/B7-H4 proteolytic axis reinvigorates therapeutic efficacy of ADCs","volume":"11","author":"Zeng","year":"2024","journal-title":"Adv. Sci."},{"key":"10.1016\/j.biopha.2025.118916_bib97","doi-asserted-by":"crossref","first-page":"515","DOI":"10.6004\/jnccn.2023.7026","article-title":"Blastic plasmacytoid dendritic cell neoplasm","volume":"21","author":"Jain","year":"2023","journal-title":"J. Natl. Compr. Cancer Netw."},{"key":"10.1016\/j.biopha.2025.118916_bib98","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.cell.2011.08.037","article-title":"Beclin1 controls the levels of p53 by regulating the deubiquitination activity of USP10 and USP13","volume":"147","author":"Liu","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.biopha.2025.118916_bib99","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1038\/s41401-020-0455-x","article-title":"Wu-5, a novel USP10 inhibitor, enhances crenolanib-induced FLT3-ITD-positive AML cell death via inhibiting FLT3 and AMPK pathways","volume":"42","author":"Yu","year":"2021","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.biopha.2025.118916_bib100","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1038\/nchembio.2486","article-title":"Inhibition of USP10 induces degradation of oncogenic FLT3","volume":"13","author":"Weisberg","year":"2017","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.biopha.2025.118916_bib101","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/bab.1715","article-title":"Cai's Neiyi Prescription promotes apoptosis and inhibits inflammation in endometrial stromal cells with endometriosis through inhibiting USP10","volume":"66","author":"Li","year":"2019","journal-title":"Biotechnol. Appl. Biochem."},{"key":"10.1016\/j.biopha.2025.118916_bib102","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.lfs.2018.07.027","article-title":"Quercetin suppresses the mobility of breast cancer by suppressing glycolysis through Akt-mTOR pathway mediated autophagy induction","volume":"208","author":"Jia","year":"2018","journal-title":"Life Sci."},{"key":"10.1016\/j.biopha.2025.118916_bib103","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1038\/s41401-023-01072-z","article-title":"Investigation of targets and anticancer mechanisms of covalently acting natural products by functional proteomics","volume":"44","author":"Zhao","year":"2023","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.biopha.2025.118916_bib104","doi-asserted-by":"crossref","DOI":"10.1172\/JCI187202","article-title":"Inhibiting inflammation in adipocytes accelerates mammary tumor development in mice","volume":"135","author":"Kim","year":"2025","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.biopha.2025.118916_bib105","doi-asserted-by":"crossref","first-page":"5166","DOI":"10.1039\/D5FO01116G","article-title":"Dietary supplementation with beetroot modulates gut microbiota-derived diacylglycerol biosynthesis to enhance anti-tumor immunity in MMTV-PyMT (FVB) mice","volume":"16","author":"Fu","year":"2025","journal-title":"Food Funct."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225011102?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225011102?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T18:47:35Z","timestamp":1777574855000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332225011102"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":105,"alternative-id":["S0753332225011102"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118916","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dual faces of USP10 in breast cancer: Oncogenic driver, tumor suppressor, and emerging therapeutic target","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118916","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"118916"}}